M

Maximilian Merz

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-2805-5973

185 papers and 1.8k citations.

PubIndex Score38Top 62% · seniorHow it's scored

185Publications

1.8kTotal Citations

First publication: 1963First senior author: 1967

Top publicationsby citations

Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy

Thomas Georgi, Vladan Vučinić, Timm Denecke et al.|Journal of Cancer Research and Clinical Oncology|2023

Cited by 25

The Differences between Ide-Cel and Cilta-Cel in Relapsed Myeloma at Single Cell Resolution

David Fandrei, Maximilian Merz, Michael Rade et al.|Blood|2024

Cited by 4

Rapid Response to Idecabtagene Vicleucel in a Myeloma Patient Refractory to Multiple Prior Lines of Anti-BCMA Directed Therapies

Maximilian Merz, Uwe Platzbecker, Vladan Vučinić et al.|Blood|2022

Cited by 1

Collections of Autologous Lymphocytes for Treatment with Chimeric Antigen Receptor (CAR) T-Lymphocytes - No Association of Clonal Hematopoiesis (CH) with Manufacturing Success

Simon M. Krauß, Vladan Vučinić, Konstantin Weibl et al.|Blood|2022

Cited by 0

Cellular dynamics and their impact on outcome in patients with mantle cell lymphoma during treatment with chimeric antigen receptor (CAR) T cells

R. Weiß, Vladan Vučinić, C. P. Fernandez et al.|Hematological Oncology|2023

Cited by 0

Indexing the rest of 185 publications…